The total WMH burden was significantly higher among patients with older age, hypertension, prior stroke or TIA, history of anti-platelet or anti-hypertensive agent usage, lower eGFR levels, and higher SBP, hs-CRP, Hcy, TMAO, and choline levels (Supplementary Table 2). The gene discussed is CRP; the disease is transient ischemic attack.